Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 214

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 214
---
 • |     | assume any and all vacation and paid time off balances of continuing employees, and assume all costs and notice 
 obligations incurred in connection with terminations of non-continuing employees; and                           |

| • |     | for the purposes of each post-closing plan that provides health benefits to any continuing employee in the year                                                                                                                            
 in which the closing occurs, use its reasonable best efforts to (i) waive all limitations as to pre-existing and at-work conditions, waiting periods, required                                                                             
 physical examinations and exclusions with respect to participation and coverage requirements for such continuing employees and their eligible dependents to the same extent that such pre-existing conditions,                             
 waiting periods, required physical examinations and exclusions would not have applied or would have been waived under the corresponding Enfusion benefit plans and (ii) credit each continuing employee and their eligible dependents with 
 deductible payments and co-payments incurred by such continuing employee and their covered dependents prior to the Effective Time.                                                                                                         |

If requested in writing by Clearwater no later than ten business days prior to the Effective Time, Enfusion will adopt written resolutions to terminate, effective as of no later than immediately before the Closing Date, any Enfusion benefit plan sponsored by Enfusion or its subsidiaries that is intended to qualify as a qualified cash or deferred arrangement within the meaning of Section 401(k) of the Code. Prior to making any written or oral communications intended for broad-based or general distributions to continuing employees pertaining to compensation or benefit matters that are affected by the Merger Agreement, Enfusion will provide Clearwater with a copy of the intended communication. 136

Director and Officer Indemnification and Insurance

The Merger Agreement provides that, for six years after the Effective Time, the Surviving Corporation will, and Clearwater will cause the
Surviving Corporation to, maintain officers’ and directors’ liability insurance in respect of acts, errors or omissions occurring prior to the Effective Time covering each such person currently covered by Enfusion’s and its
subsidiaries’ officers’ and directors’ liability insurance policy on terms with respect to coverage and amount no less favorable than those of such policy in effect on the date of the Merger Agreement. Neither Clearwater nor the
Surviving Corporation will be obligated to pay annual premiums in excess of 300% of the amount per annum Enfusion paid in its last full fiscal year, and if such premiums for such insurance at any time exceeds such amount, then the Surviving
Corporation will cause to be maintained policies of insurance